Dow Jones Top Company Headlines at 7 PM ET: OpenAI Plans Launch of Desktop 'Superapp' to Refocus, Simplify User Experience | Unilever ...

Dow Jones
03/20

OpenAI Plans Launch of Desktop 'Superapp' to Refocus, Simplify User Experience

The AI company will combine ChatGPT, Codex app and browser in an effort to focus and streamline its resources.

----

Unilever in Talks to Separate Food Business and Combine It With McCormick

The remaining Unilever company would focus on beauty, personal-care products and home.

----

FedEx Posts Higher Third-Quarter Sales, Boosts Outlook

The company expects revenue to grow 6% to 6.5% for the full year, up from its prior forecast of 5% to 6% growth.

----

Jeff Bezos in Talks to Raise $100 Billion for AI Manufacturing Fund

The Amazon.com founder has traveled to the Middle East and Singapore in a fundraising effort linked to the Project Prometheus AI startup.

----

Kalshi Cinches $22 Billion Valuation in Ongoing Round

Coatue Management is leading the new financing that would total about $1 billion for the prediction-market platform, according to sources.

----

Live Nation CEO Grilled Over Ticket Fees at Antitrust Trial

The executive was questioned about past comments boasting of the concert promoter's dominance and profitability.

----

Uber to Invest Up to $1.25 Billion in Rivian Robotaxis

The partnership could bring thousands of Rivian R2 robotaxis to cities in the U.S., Canada and Europe.

----

Novo Nordisk's Higher Dose Wegovy Weight-Loss Drug Gains U.S. Approval

The Danish drugmaker said the accelerated approval was based on results from its Step Up trial, which showed 20.7% mean weight loss for participants with obesity.

----

Scholastic to Repurchase $200 Million in Stock Through Modified Dutch Auction

The publishing house said the offer will run between March 23 and April 20, with an expected cash purchase price of between $36 and $40 a share.

----

Ecolab Nears Deal for KKR's Data-Center Cooling Company

Ecolab is set to pay between $4.5 billion and $5 billion for the business.

----

Lilly's Retatrutide Shows Significant Improvement In Weight Loss and Blood Sugar

Eli Lilly's experimental weight-loss drug retatrutide met the primary and key secondary endpoints in a trial, showing significant reductions in weight loss and blood sugar levels.

----

Alibaba Earnings Disappoint, but AI Outlook Bright

The Chinese tech giant is zeroing in on making AI a key engine of growth, continuing to upgrade its Qwen model series and integrating it into its core ecosystem.

----

3M, Bain Capital to Buy Madison Fire & Rescue, Form Safety Venture

3M is teaming up Bain Capital to buy Madison Fire & Rescue for $1.95 billion as part of a deal to form a new fire and safety venture.

----

Accenture Revenue Rises as AI Adoption Boosts Bookings

Accenture reported higher second-quarter revenue as companies' AI adoption continues to drive demand for its services.

----

Tesla Faces Expanded U.S. Probe Over Self-Driving Performance in Poor Weather

The escalation by federal safety regulators could result in a recall campaign or other enforcement action.

----

Darden Sales Rise, Boosted by LongHorn Steakhouse

Darden Restaurants reported higher third-quarter sales, led by growth in its LongHorn Steakhouse brand.

----

Samsung to Invest Over $70 Billion in Bid for Edge in AI Chips Race

Samsung Electronics plans to invest over $70 billion this year to vie for dominance in manufacturing artificial-intelligence chips.

----

Eight States Sue to Block $6.2 Billion Nexstar-Tegna Merger

California, New York and others argue the deal would result in excessive concentration in some local TV markets.

 

(END) Dow Jones Newswires

March 19, 2026 19:00 ET (23:00 GMT)

Copyright (c) 2026 Dow Jones & Company, Inc.

应版权方要求,你需要登录查看该内容

免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。

热议股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10